Atlanta Institute of Medicine and Research

Atlanta, Georgia 30328

0 studies enrolling now · 10 studies all time

What they study most

Attention-deficit/Hyperactivity Disorder, Binge Eating Disorder, Major Depressive Disorder, Major Depressive Disorder (MDD), Opioid Dependence, Treatment Resistant Depression

Studies at this site

• Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder — Completed
• Open Label Extension in Adults With Binge Eating Disorder (BED) — Completed
• Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder — Completed
• A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression — Stopped early
• Genomics Used to Improve DEpression Decisions — Completed
• ALK21-025: Vivitrol's Cost and Treatment Outcomes Registry — Completed
• Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants — Completed
• Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression — Completed
• Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD) — Completed
• A Efficacy Study of PRX-00023 in Patients With Major Depressive Disorder — Completed